DNAVSRM• 3 Months (Normalized)
DNA vs RM (Ginkgo Bioworks Holdings Inc. vs Regional Management Corp.)
Showing Closing Date Range from Jul 9 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $11.47
+17.88%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
RM Performance $33.2
+9.1%
Regional Management Corp.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
+8.78 pts
DNA outperforming by 8.78 percentage points
DNARM
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA RM
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(64 dates)
| Date | DNA Price | DNA Gain (%) | RM Price | RM Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 07, 2026 | $11.47 | +17.88% | $33.20 | +9.10% | +8.78% |
| Oct 06, 2026 | $12.41 | +27.54% | $32.80 | +7.79% | +19.75% |
| Oct 05, 2026 | $14.98 | +53.96% | $32.77 | +7.69% | +46.27% |
| Oct 02, 2026 | $12.35 | +26.93% | $31.80 | +4.50% | +22.43% |
| Oct 01, 2026 | $12.50 | +28.47% | $30.99 | +1.84% | +26.63% |
| Sep 30, 2026 | $12.83 | +31.86% | $30.23 | -0.66% | +32.52% |
| Sep 29, 2026 | $11.96 | +22.92% | $30.57 | +0.46% | +22.46% |
| Sep 28, 2026 | $10.46 | +7.50% | $30.43 | +0.00% | +7.50% |
| Sep 25, 2026 | $10.66 | +9.56% | $- | - | |
| Sep 24, 2026 | $10.25 | +5.34% | $- | - | |
| Sep 23, 2026 | $8.58 | -11.82% | $- | - | |
| Sep 22, 2026 | $9.37 | -3.70% | $- | - | |
| Sep 21, 2026 | $7.98 | -17.99% | $- | - | |
| Sep 18, 2026 | $7.88 | -19.01% | $- | - | |
| Sep 17, 2026 | $7.84 | -19.42% | $- | - |
Page 1 of 5